These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 4850181)

  • 1. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
    Nilsson LH; Hultman E
    Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver changes in Crohn's disease and ulcerative colitis].
    Eckhardt R
    Dtsch Med Wochenschr; 1978 Dec; 103(50):1983-5. PubMed ID: 720230
    [No Abstract]   [Full Text] [Related]  

  • 4. Galactose retention: an alternative to the bromsulphthalein test.
    Sinniah D
    Singapore Med J; 1974 Dec; 15(4):273-5. PubMed ID: 4458070
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatobiliary complications of chronic inflammatory bowel diseases].
    Walker S; Bode JC
    Med Klin (Munich); 1990 Oct; 85(10):608-15. PubMed ID: 2233592
    [No Abstract]   [Full Text] [Related]  

  • 6. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
    Tengström B
    Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatobiliary diseases in Crohn disease and ulcerative colitis].
    Kruis W
    Leber Magen Darm; 1987 Feb; 17(1):28, 31-2, 35-6. PubMed ID: 3561141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral galactose tolerance test in liver diseases. Studies on technics and on the evaluation of results].
    Hennecke A; König KJ; Südhof H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):109-14 passim. PubMed ID: 5008209
    [No Abstract]   [Full Text] [Related]  

  • 9. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The liver and bilary tract in inflammatory bowel disease (author's transl)].
    Pariente EA
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1120-31. PubMed ID: 7319208
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simultaneous bromsulfalein and galactose loading as a liver function test].
    Nilsson LH; Hultman E
    Nord Med; 1971 Aug; 85(31):942-3. PubMed ID: 5569721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relation between sulfobromophthalein Au-198 clearance and scintigraphic aspects in hepatopathies].
    Maduli S; Castagnetti GL
    G Clin Med; 1970 Mar; 51(3):180-256. PubMed ID: 5477744
    [No Abstract]   [Full Text] [Related]  

  • 13. The spectrum of hepatic dysfunction in inflammatory bowel disease.
    Dew MJ; Thompson H; Allan RN
    Q J Med; 1979 Jan; 48(189):113-35. PubMed ID: 482586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with bromsulfan in liver diagnosis].
    Lemke E
    Z Arztl Fortbild (Jena); 1967 Aug; 61(16):813-6. PubMed ID: 5592668
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions.
    Salaspuro MP; Kesäniemi YA
    Scand J Gastroenterol; 1973; 8(7):681-6. PubMed ID: 4768313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of the ujoviridine test as compared with the bromsulfan test in acute and chronic hepatopathies].
    Wildt F; Wagner K; Wildt S
    Z Arztl Fortbild (Jena); 1977 Sep; 71(18):841-3. PubMed ID: 595629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading].
    Järnerot G
    Nord Med; 1970 Dec; 84(50):1586-8. PubMed ID: 5519422
    [No Abstract]   [Full Text] [Related]  

  • 18. Can serum bile acid determination substitute BSP loading test in detecting and monitoring chronic liver diseases?
    Mazzanti R; Chiarantini E; Baronti E; Moscarella S; Arena U; Buzzelli G
    Boll Soc Ital Biol Sper; 1986 Feb; 62(2):219-26. PubMed ID: 3087392
    [No Abstract]   [Full Text] [Related]  

  • 19. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
    Rommel K; Grimmel K
    Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alkaline leucocyte phosphatase (ALP) in acute and chronic liver diseases].
    Krug K; Stenzel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):170-9. PubMed ID: 4122960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.